IP Library Granted Patent US 11,850,421
Granted Patent B2
US 11,850,421 · App. 17/314,659 · Granted Dec 26, 2023

Compositions and methods of applying alternating electric fields to pluripotent stem cells

Inventor: Tali Voloshin-Sela (Haifa, IL)
Assignee: NOVOCURE GMBH
A61N1/36A61N1/36002A61N1/0476
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,850,421
App. No.
17/314,659
Granted
Dec 26, 2023
Kind
B2
Abstract

Disclosed are methods and compositions for preventing or disrupting mitosis of pluripotent stem cells, killing pluripotent stem cells, preventing or disrupting division of pluripotent stem cells, reducing the viability of pluripotent stem cells, slowing the progression or differentiation of pluripotent stem cells, and treating an ectopic pregnancy.

Claims (15)

1. A method of treating ectopic pregnancy comprising:

a. applying an alternating electric field to a target site of the subject for a period of time, the alternating electric field having a frequency and field strength,

wherein the target site comprises an ectopic pregnancy,

b. introducing a nanoparticle to the target site in the subject; and

c. applying an alternating electric field to the target site of the subject,

wherein the electric impedance in the target site of the subject to the alternating electric field is altered.

2. The method of claim 1 , wherein the current density and/or power loss density in the target site of the subject to the alternating current is altered.

3. The method of claim 1 , wherein the nanoparticle is a conductive nanoparticle.

4. The method of claim 3 , wherein the impedance in the target site is lowered.

5. The method of claim 3 , wherein the conductivity in the target site is increased.

6. The method of claim 1 , wherein the nanoparticle is a non-conductive nanoparticle.

7. The method of claim 6 , wherein the impedance in the target site is increased.

8. The method of claim 6 , wherein the conductivity in the target site is decreased.

9. The method of claim 1 , wherein the nanoparticle is introduced into a pluripotent stem cell in the target site.

10. The method of claim 1 , wherein the frequency is 25 kHz to 1 MHz.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2021
From: VOLOSHIN SELA, TALI
To: NOVOCURE GMBH
Reel/Frame 058021/0562 →